Citations

1. Burns P, et al. (2003). Management of peripheral arterial disease in primary care. BMJ, 326(7389): 584–588.

2. White C (2007). Intermittent claudication. New England Journal of Medicine, 356(12): 1241–1250.

3. Hirsch AT, et al. (2006). ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation, 113(11): e463–e654.

4. Mehler PS, et al. (2003). Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation, 107(5): 753–756.

5. Regensteiner JG, Hiatt WR (2002). Current medical therapies for patients with peripheral arterial disease: A critical review. American Journal of Medicine, 112(1): 49–57.

6. Mohler ER III, et al., (2003). Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation, 108(12): 1481–1486.

7. Cassar K, Bachoo P (2006). Peripheral arterial disease, search date December 2005. Online version of Clinical Evidence (15).

Other Works Consulted

• American Heart Association and American College of Cardiology (2006). AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation, 113(19): 2363–2372. [Erratum in Circulation, 113(22): 847.]

• Hiatt WR (2001). Medical treatment of peripheral arterial disease and claudication. New England Journal of Medicine, 344(21): 1608–1621.

• Husten CG, Thorne SL (2008). Tobacco: Health effects and control. In RB Wallace, ed., Maxcy-Rosenau-Last Public Health and Preventive Medicine, 15th ed., pp. 953–998. New York: McGraw-Hill.

• Norgren L, et al. (2007). Inter-society consensus for the management of peripheral arterial disease (TASC II). European Journal of Vascular Surgery, 33 (Suppl 1): S1–S70.